I-Mab
NASDAQ:IMAB

Watchlist Manager
I-Mab Logo
I-Mab
NASDAQ:IMAB
Watchlist
Price: 0.8394 USD -1.51% Market Closed
Market Cap: 67.9m USD

Wall Street
Price Targets

IMAB Price Targets Summary
I-Mab

Wall Street analysts forecast IMAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMAB is 5.1 USD with a low forecast of 4.04 USD and a high forecast of 6.3 USD.

Lowest
Price Target
4.04 USD
381% Upside
Average
Price Target
5.1 USD
508% Upside
Highest
Price Target
6.3 USD
651% Upside
I-Mab Competitors:
Price Targets
ORGO
Organogenesis Holdings Inc
34% Upside
688520
Sinocelltech Group Ltd
47% Upside
NBIX
Neurocrine Biosciences Inc
48% Upside
GILD
Gilead Sciences Inc
11% Upside
SANA
Sana Biotechnology Inc
447% Upside
206650
EuBiologics Co Ltd
33% Upside
086890
Isu Abxis Co Ltd
85% Upside
SVE
Synthaverse SA
48% Upside

Revenue
Forecast

Revenue Estimate
I-Mab

For the last 5 years the compound annual growth rate for I-Mab's revenue is -12%.

-12%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
I-Mab

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
I-Mab

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMAB's stock price target?
Price Target
5.1 USD

According to Wall Street analysts, the average 1-year price target for IMAB is 5.1 USD with a low forecast of 4.04 USD and a high forecast of 6.3 USD.

Back to Top